Scientific article
Comment
OA Policy
English

Bosutinib-related pneumonitis

Published inThe European respiratory journal, vol. 50, no. 3, 1700930
Publication date2017-09
First online date2017-09-12
Abstract

Comment on : Hickey PM, Thompson AA, Charalampopoulos A, Elliot CA, Hamilton N, Kiely DG, Lawrie A, Sabroe I, Condliffe R. Bosutinib therapy resulting in severe deterioration of pre-existing pulmonary arterial hypertension. Eur Respir J. 2016 Nov;48(5):1514-1516. doi: 10.1183/13993003.01004-2016. Epub 2016 Sep 22. PMID: 27660511.

And on : Riou M, Seferian A, Savale L, Chaumais MC, Guignabert C, Canuet M, Magro P, Rea D, Sitbon O, Jaïs X, Humbert M, Montani D. Deterioration of pulmonary hypertension and pleural effusion with bosutinib following dasatinib lung toxicity. Eur Respir J. 2016 Nov;48(5):1517-1519. doi: 10.1183/13993003.01410-2016. Epub 2016 Oct 6. PMID: 27799395.

Keywords
  • Aniline Compounds
  • Antineoplastic Agents
  • Humans
  • Nitriles
  • Pneumonia
  • Protein Kinase Inhibitors
  • Quinolines
Affiliation entities Not a UNIGE publication
Citation (ISO format)
JUTANT, Etienne-Marie et al. Bosutinib-related pneumonitis. In: The European respiratory journal, 2017, vol. 50, n° 3, p. 1700930. doi: 10.1183/13993003.00930-2017
Main files (1)
Article (Published version)
Identifiers
Journal ISSN0903-1936
12views
37downloads

Technical informations

Creation09/12/2025 14:13:44
First validation19/01/2026 14:50:23
Update24/03/2026 09:58:10
Status update24/03/2026 09:58:10
Last indexation24/03/2026 10:00:48
All rights reserved by Archive ouverte UNIGE and the University of GenevaunigeBlack